Jotam G. Pasipanodya, D.P.H.
Affiliations: | 2008 | University of North Texas Health Science Center at Fort Worth |
Area:
Public Health, EpidemiologyGoogle:
"Jotam Pasipanodya"Cross-listing: PHTree
Parents
Sign in to add mentor| Peter Eric Hilsenrath | grad student | 2008 | University of North Texas Health Science Center at Fort Worth | |
| (Disability-adjusted life years lost due to adult pulmonary tuberculosis in Tarrant County, 2005--2006: An analysis of the role of post-tuberculosis impairment.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gumbo T, Srivastava S, Deshpande D, et al. (2023) Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development. The Journal of Antimicrobial Chemotherapy |
| Deshpande D, Srivastava S, Pasipanodya JG, et al. (2022) Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy. Frontiers in Pharmacology. 13: 1024608 |
| Heysell SK, Mpagama SG, Ogarkov OB, et al. (2022) Pharmacokinetic-pharmacodynamic determinants of clinical outcomes for rifampin-resistant tuberculosis: a multi-site prospective cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Srivastava S, Pasipanodya JG, Heysell SK, et al. (2021) An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease. Journal of Global Antimicrobial Resistance |
| Magombedze G, Pasipanodya JG, Gumbo T. (2021) Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse. Communications Biology. 4: 664 |
| Allwood BW, van der Zalm MM, Amaral AFS, et al. (2020) Post-tuberculosis lung health: perspectives from the First International Symposium. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 24: 820-828 |
| Zentner I, Back HM, Kagan L, et al. (2020) Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study. Frontiers in Pharmacology. 11: 1103 |
| Sibandze DB, Magazi BT, Malinga LA, et al. (2020) Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis. Bmc Infectious Diseases. 20: 556 |
| Pasipanodya JG, Gumbo T. (2019) Dosing tuberculosis drugs in young children: the road ahead. The Lancet. Child & Adolescent Health |
| Mehta K, Ravimohan S, Pasipanodya JG, et al. (2019) Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study. The Journal of Antimicrobial Chemotherapy |